D. Boral Capital Reaffirms “Buy” Rating for Anavex Life Sciences (NASDAQ:AVXL)
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at D. Boral Capital in a report released on Monday,Benzinga reports. They currently have a $46.00 price target on the biotechnology company’s stock. Separately, HC Wainwright reiterated a “buy” rating and set a $42.00 target price on shares […]
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at D. Boral Capital in a report released on Monday,Benzinga reports. They currently have a $46.00 price target on the biotechnology company’s stock. Separately, HC Wainwright reiterated a “buy” rating and set a $42.00 target price on shares […]